UNITED THERAPEUTICS Corp ($UTHR)
Filing Information
| Accession Number | 0001106578-26-000026 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 6, 2026 |
| Document | View SEC Filing |
Transactions
20
Total Shares
28,500
Total Value
$6,720,337.72
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Apr 2, 2026 | Exercise/Conversion | 9,500 | $146.03 | $1,387,285.00 | 50,013 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 2, 2026 | Sale | 65 | $552.25 | $35,896.05 | 49,948 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 2, 2026 | Sale | 175 | $553.50 | $96,861.87 | 49,773 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 2, 2026 | Sale | 394 | $554.45 | $218,455.23 | 49,379 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 2, 2026 | Sale | 1,058 | $555.41 | $587,623.99 | 48,321 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 2, 2026 | Sale | 808 | $556.52 | $449,666.95 | 47,513 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 2, 2026 | Sale | 780 | $557.40 | $434,770.75 | 46,733 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 2, 2026 | Sale | 440 | $558.51 | $245,744.40 | 46,293 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 2, 2026 | Sale | 40 | $559.98 | $22,399.20 | 46,253 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 2, 2026 | Sale | 570 | $561.60 | $320,109.61 | 45,683 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 2, 2026 | Sale | 378 | $562.49 | $212,619.90 | 45,305 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 2, 2026 | Sale | 865 | $563.52 | $487,447.40 | 44,440 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 2, 2026 | Sale | 1,918 | $564.55 | $1,082,814.19 | 42,522 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 2, 2026 | Sale | 811 | $565.38 | $458,519.45 | 41,711 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 2, 2026 | Sale | 570 | $566.39 | $322,843.44 | 41,141 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 2, 2026 | Sale | 308 | $567.70 | $174,853.11 | 40,833 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 2, 2026 | Sale | 120 | $568.53 | $68,223.60 | 40,713 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 2, 2026 | Sale | 80 | $570.05 | $45,604.00 | 40,633 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 2, 2026 | Sale | 120 | $571.66 | $68,599.60 | 40,513 | Direct | โ | View Details | |
Director | Stock Option | Derivative | Apr 2, 2026 | Exercise/Conversion | 9,500 | $0.00 | $0.00 | 12,000 | Direct | โ | View Details |